120 related articles for article (PubMed ID: 38079)
1. Metabolism and disposition by the rat of 35S-sulfadiazine alone and in the presence of trimethoprim.
Woolley JL; Sigel CW
Drug Metab Dispos; 1979; 7(2):94-9. PubMed ID: 38079
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of co-trimazine after single and multiple doses.
Leone N; Barzaghi N; Monteleone M; Perucca E; Cerutti R; Crema A
Arzneimittelforschung; 1987 Jan; 37(1):70-4. PubMed ID: 3566861
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and renal clearance of sulfamethazine, sulfamerazine, and sulfadiazine and their N4-acetyl and hydroxy metabolites in horses.
Nouws JF; Firth EC; Vree TB; Baakman M
Am J Vet Res; 1987 Mar; 48(3):392-402. PubMed ID: 3565894
[TBL] [Abstract][Full Text] [Related]
4. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of prophylactic administration of trimethoprim/sulfadiazine in a Streptococcus equi subsp. zooepidemicus infection model in ponies.
Ensink JM; Bosch G; van Duijkeren E
J Vet Pharmacol Ther; 2005 Feb; 28(1):45-9. PubMed ID: 15720514
[TBL] [Abstract][Full Text] [Related]
6. Trimethoprim-sulfadiazine in the horse: serum, synovial, peritoneal, and urine concentrations after single-dose intravenous administration.
Brown MP; Kelly RH; Stover SM; Gronwall R
Am J Vet Res; 1983 Apr; 44(4):540-3. PubMed ID: 6869949
[TBL] [Abstract][Full Text] [Related]
7. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
8. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and disposition of 1-bromopropane in rats and mice following inhalation or intravenous administration.
Garner CE; Sumner SC; Davis JG; Burgess JP; Yueh Y; Demeter J; Zhan Q; Valentine J; Jeffcoat AR; Burka LT; Mathews JM
Toxicol Appl Pharmacol; 2006 Aug; 215(1):23-36. PubMed ID: 16513153
[TBL] [Abstract][Full Text] [Related]
10. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
11. Route-dependent comparative metabolism of [14C]toluene 2,4-diisocyanate and [14C]toluene 2,4-diamine in Fischer 344 rats.
Timchalk C; Smith FA; Bartels MJ
Toxicol Appl Pharmacol; 1994 Feb; 124(2):181-90. PubMed ID: 8122263
[TBL] [Abstract][Full Text] [Related]
12. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
13. The penetration of sulfadiazine, sulfamethoxazole and trimethoprim into the prostate gland, epididymis and testis in man.
Seppänen J
Ann Clin Res; 1980; (25):47-51. PubMed ID: 6990859
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics, metabolism, and renal clearance of sulfadiazine, sulfamerazine, and sulfamethazine and of their N4-acetyl and hydroxy metabolites in calves and cows.
Nouws JF; Mevius D; Vree TB; Baakman M; Degen M
Am J Vet Res; 1988 Jul; 49(7):1059-65. PubMed ID: 3421528
[TBL] [Abstract][Full Text] [Related]
15. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.
Denissen JF; Grabowski BA; Johnson MK; Buko AM; Kempf DJ; Thomas SB; Surber BW
Drug Metab Dispos; 1997 Apr; 25(4):489-501. PubMed ID: 9107549
[TBL] [Abstract][Full Text] [Related]
16. Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans.
Scatina JA; Wells DS; Kimmel HB; Kemper CJ; Sisenwine SF
Drug Metab Dispos; 1990; 18(5):746-52. PubMed ID: 1981731
[TBL] [Abstract][Full Text] [Related]
17. Metabolism and disposition of moxonidine in Fischer 344 rats.
He MM; Abraham TL; Lindsay TJ; Chay SH; Czeskis BA; Shipley LA
Drug Metab Dispos; 2000 Apr; 28(4):446-59. PubMed ID: 10725314
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial disposition in pulmonary epithelial lining fluid of horses. Part I. Sulfadiazine and trimethoprim.
Winther L; Guardabassi L; Baptiste KE; Friis C
J Vet Pharmacol Ther; 2011 Jun; 34(3):277-84. PubMed ID: 20950347
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.
Vickers S; Duncan CA; Slaughter DE; Arison BH; Greber T; Olah TV; Vyas KP
Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219
[TBL] [Abstract][Full Text] [Related]
20. Age-related alterations in trimethoprim-sulfadiazine disposition following oral or parenteral administration in calves.
Guard CL; Schwark WS; Friedman DS; Blackshear P; Haluska M
Can J Vet Res; 1986 Jul; 50(3):342-6. PubMed ID: 3742370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
